Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-24

Clinical Trial Update: PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor [NA]

View source ↗

Summary

The PACESETTER trial evaluated electronic tracking and tailored risk-factor management to prevent cerebrovascular events in people with hypertension. Results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northern California Institute of Research and Education | Conditions: Blood Pressure, Hypertension | NA | Status: TERMINATED | Results posted: 2025-11-24